| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/27/2010 | CA2179909C Ligand that binds fas antigen |
| 04/22/2010 | WO2010045509A2 Modulation of factor 11 expression |
| 04/22/2010 | WO2010045384A2 Short hairpin rnas for inhibition of gene expression |
| 04/22/2010 | WO2010027512A9 Rna synthesis - phosphoramidites for synthetic rna in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic rna at the 3' - end |
| 04/22/2010 | WO2010025395A3 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 04/22/2010 | WO2010008474A3 Methods for treating multiple sclerosis using antisense oligonucleotides |
| 04/22/2010 | WO2010007622A3 Long-acting interferons and derivatives thereof and methods thereof |
| 04/22/2010 | WO2009145944A3 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms |
| 04/22/2010 | WO2009143155A3 Delayed fruit deterioration allele in plants and methods of detection |
| 04/22/2010 | WO2009134709A3 Polynucleotides associated with age-related macular degeneration and methods for evaluating patient risk |
| 04/22/2010 | WO2009129236A3 Method for manipulating samples with magnetic nucleation nanoparticles |
| 04/22/2010 | US20100100987 Nucleic acid molecules and other molecules associated with the tocopherol pathway |
| 04/22/2010 | US20100100986 Promoter for the high level expression in plant-tissue culture and vector using the same |
| 04/22/2010 | US20100100981 Wuschel (wus) gene homologs |
| 04/22/2010 | US20100100979 Biomarker specific for cancer |
| 04/22/2010 | US20100100978 RNAi MEDIATED EXPRESSION INHIBITION OF A CHOLINERGIC PROTEIN |
| 04/22/2010 | US20100100976 Methods and compositions related to apobec-1 expression |
| 04/22/2010 | US20100100975 Silk proteins |
| 04/22/2010 | US20100099900 Delta-8 desaturases and their use in making polyunsaturated fatty acids |
| 04/22/2010 | US20100099860 Capture molecules for the detection of amplicons with high sensitivity |
| 04/22/2010 | US20100099859 Soybean event mon89788 and methods for detection thereof |
| 04/22/2010 | US20100099858 Maximizing Oligonucleotide Loading on Gold Nanoparticle |
| 04/22/2010 | US20100099854 Neurovirulent strain of the west nile virus and uses thereof |
| 04/22/2010 | US20100099750 Chemically modified short interfering nucleic acid molecule for use in treatment of respiratory and pulmonary disease |
| 04/22/2010 | US20100099749 Nucleic Acid Inhibitors Of Glutamate Receptors |
| 04/22/2010 | US20100099748 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes |
| 04/22/2010 | US20100099746 Novel nucleic acid |
| 04/22/2010 | US20100099744 RNA INTERFERENCE MEDIATED INHIBITION OF MATRIX METALLOPROTEINASE 13 (MMP13) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/22/2010 | US20100099743 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/22/2010 | US20100099740 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 04/22/2010 | US20100099739 Compositions and Methods for Gene Silencing |
| 04/22/2010 | US20100099627 Nuclear targeting sequences |
| 04/22/2010 | US20100099617 Secreted proteins |
| 04/22/2010 | US20100099610 Transglutaminase Variants with Improved Specificity |
| 04/22/2010 | US20100099598 Amylase Variants |
| 04/22/2010 | US20100099597 Amylase Variants |
| 04/22/2010 | US20100099578 siRNA Targeting Fructose-1, 6-bisphosphatase 1 (FBP1) |
| 04/22/2010 | US20100099191 Rna interference tags |
| 04/22/2010 | US20100099184 Polynucleotides encoding class ii cytokine receptor-7 |
| 04/22/2010 | US20100099168 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex |
| 04/22/2010 | US20100099167 for producing beta-alanine, pantothenate, 3-hydroxypropionic acid, as well as other organic compounds |
| 04/22/2010 | US20100099159 Caged nucleotides and oligonucleotides and their application |
| 04/22/2010 | US20100099154 Pufa polyketide synthase systems and uses thereof |
| 04/22/2010 | US20100099149 Stabilizing compositions and methods for extraction of ribonucleic acid |
| 04/22/2010 | US20100099147 Anti-IGF-1R Antibodies and Uses Thereof |
| 04/22/2010 | US20100099146 Variants of Beta-Glucosidases |
| 04/22/2010 | US20100099145 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 04/22/2010 | US20100099144 Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells |
| 04/22/2010 | US20100099122 Ferric reductase activity of histoplasma capsulatum y-glutamyltransferase |
| 04/22/2010 | US20100099110 Allele-Specific Amplification |
| 04/22/2010 | US20100099104 Genetic test for the identification of carriers of complex vertebral malformations in cattle |
| 04/22/2010 | US20100099103 Antibody Libraries |
| 04/22/2010 | US20100099098 Methods and compositions for diagnosing and monitoring transplant rejection |
| 04/22/2010 | US20100099086 Method and apparatus for determining a probability of colorectal cancer in a subject |
| 04/22/2010 | US20100099082 Allele Detection |
| 04/22/2010 | US20100099078 Method for designing a drug regime for hiv-infected patients |
| 04/22/2010 | US20100098775 Detecting genetic predisposition to osteoarthritis associated conditions |
| 04/22/2010 | US20100098737 methods and compositions for delivery of glycopeptide antibiotics to medical device surfaces |
| 04/22/2010 | US20100098719 Fusion Proteins Comprising Two or More IgG Binding Domains of Streptococcal Protein G |
| 04/22/2010 | US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 04/22/2010 | US20100098711 Antagonist antibodies against ephb3 |
| 04/22/2010 | US20100098709 Antibodies Specific For The Complex Of Interleukin-6 And The Interleukin-6 Receptor |
| 04/22/2010 | US20100098706 Monoclonal antibody directed against the human ldl receptor |
| 04/22/2010 | US20100098695 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 04/22/2010 | US20100098694 Antibodies to cd40 |
| 04/22/2010 | US20100098692 Humanized Endoglin Antibodies |
| 04/22/2010 | US20100098683 MUC1 and Galectin-3 |
| 04/22/2010 | US20100098663 Methods of Inhibiting Tumor Cell Proliferation with FoxM1 siRNA |
| 04/22/2010 | CA2740785A1 Modulation of factor 11 expression |
| 04/21/2010 | EP2177627A1 Manipulation of microparticles in microfluidic systems |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2176281A1 Nucleic acid sequences and combination thereof for sensitive amplification and detection of bacterial and fungal sepsis pathogens |
| 04/21/2010 | EP2176280A2 6-disubstituted bicyclic nucleic acid analogs |
| 04/21/2010 | EP2176277A2 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof |
| 04/21/2010 | EP1654355B1 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products |
| 04/21/2010 | EP1364063B1 Detection of herpes simplex virus |
| 04/21/2010 | EP1066506B1 Method and apparatus for synthesis of arrays of dna probes |
| 04/21/2010 | CN101696408A Method for extracting DNA from single eggs of copepods |
| 04/20/2010 | US7700853 Inbred corn line XHH13 |
| 04/20/2010 | US7700851 Tobacco nicotine demethylase genomic clone and uses thereof |
| 04/20/2010 | US7700838 4-hydroxyphenylpyruvate dioxygenases; transformed seeds, cells |
| 04/20/2010 | US7700835 AGPase promoter from rice and uses thereof |
| 04/20/2010 | US7700761 3-deoxypentopyranosyl nucleic acid, its production and its use |
| 04/20/2010 | US7700760 RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA) |
| 04/20/2010 | US7700759 Aptamer constructs |
| 04/20/2010 | US7700757 for treatment of chronic inflammatory bowel disease, Crohn's disease and ulcerative colitis |
| 04/20/2010 | US7700756 Nucleotide sequences for identifying perclorate reducing microorganisms; bioremediation of rocket fuels |
| 04/20/2010 | US7700755 cytotoxins; host cells; vaccines; histology |
| 04/20/2010 | US7700754 Polypeptide for unstabilizing protein in cells under aerobic conditions and DNA encoding the same |
| 04/20/2010 | US7700753 Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof |
| 04/20/2010 | US7700752 Microorganisms engineered to express both cytochrome P-450 and the ferredoxin or ferrerdoxin-like protein; hypercholesterolemia and hyperlipidemia; host cells |
| 04/20/2010 | US7700751 Immunoglobulin light chain for prevention and treatment of alzheimers; host cells |
| 04/20/2010 | US7700750 kit for detection and characterization of mutations associated with non-syndromic hearing impairment |
| 04/20/2010 | US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer |
| 04/20/2010 | US7700748 VMGLOM gene and its mutations causing disorders with a vascular component |
| 04/20/2010 | US7700736 PRO350 antibodies |
| 04/20/2010 | US7700574 Receptor activator of NF-kappaB ligand (RANKL); antisense agents; drug screening; kits |
| 04/20/2010 | US7700572 SMAD7 inhibitors for the treatment of CNS diseases |
| 04/20/2010 | US7700571 Compositions and methods for liver growth and liver protection |
| 04/20/2010 | US7700570 Oligonucleotide mediated specific cytokine induction and prophylaxis and treatment of viral infection in a mammal |